| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $28.7K | +1.1K | +0.16% | $26.10 | 669K | Jan 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$162K | -1.1K | -0.16% | $147.16 | 668K | Jan 7, 2022 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $84.1K | +3.22K | +0.48% | $26.10 | 671K | Jan 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$470K | -3.22K | -0.48% | $145.84 | 668K | Jan 7, 2022 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Options Exercise | $119K | +4.56K | +0.68% | $26.10 | 673K | Jan 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$660K | -4.56K | -0.68% | $144.82 | 668K | Jan 7, 2022 | Direct | F1, F2, F5 |
| transaction | SGEN | Common Stock | Options Exercise | $213K | +8.16K | +1.22% | $26.10 | 676K | Jan 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$1.17M | -8.16K | -1.21% | $143.91 | 668K | Jan 7, 2022 | Direct | F1, F2, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1.1K | -0.81% | $0.00 | 135K | Jan 7, 2022 | Common Stock | 1.1K | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -3.22K | -2.38% | $0.00 | 132K | Jan 7, 2022 | Common Stock | 3.22K | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -4.56K | -3.45% | $0.00 | 127K | Jan 7, 2022 | Common Stock | 4.56K | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -8.16K | -6.4% | $0.00 | 119K | Jan 7, 2022 | Common Stock | 8.16K | $26.10 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $146.71 to $147.68. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $145.42 to $146.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $144.41 to $145.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Reflects sales of common stock executed in multiple transactions at prices ranging from $143.41 to $144.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F7 | Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16. |